Skip to content
Artwork for MedEdTalks - Ophthalmology
Health & FitnessMedicineScience

MedEdTalks - Ophthalmology

Vindico Medical Education

MedEdTalks Ophthalmology is an accredited educational podcast for providers to learn more about treating patients with Ophthalmology diseases/disorders. Discover all content and topics by visiting mededtalks.com.

Play
  • 31 episodes
  • Avg 27 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • Yesterday · 47 min

    A New Era in TED: Navigating Choice, Sequencing, and Long-Term Care

    The management of thyroid eye disease (TED) is entering a new era marked by the availability of multiple FDA-approved IGF-1R-targeted therapies and a growing pipeline of emerging treatment options. As the treatment landscape continues to evolve, clinicians require practical guidance to make informed, patient-centered therapeutic decisions across the disease continuum. Delivered in a dynamic Rapid-Fire Roundtable format, this activity will provide participants with expert insights into available therapies, highlighting key differences in clinical evidence, safety profiles, patient selection, retreatment strategies, and challenges to real-world implementation. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box:

  • November 1 · 46 min· Video

    S4E1: The Retina Radar Season 4 With Dr. Arshad Khanani: Clinical Trials at the Summit 2026 With Drs. David Boyer and Anat Loewenstein

    In this podcast, expert faculty review the therapeutic landscape of vitreoretinal care and discuss the latest from Clinical Trials at the Summit 2026. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://vindicocme.com/mededtalks/1the-retina-radar-season-4-with-dr-arshad-khanani-clinical-trials-at-the-summit-2026-with-drs-david-boyer-and-anat-loewenstein-blt810e98f995192db2/overview

  • October 31 · 42 min· Video

    S4E4: The Retina Radar Season 4 With Dr. Arshad Khanani: What's New for RVO in 2026? With Dr. Ehsan Rahimy

    In this podcast, expert faculty discuss current treatment strategies and emerging clinical data to optimize outcomes for patients with RVO. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://vindicocme.com/mededtalks/4the-retina-radar-season-4-with-dr-arshad-khanani-what-s-new-for-rvo-in-2026-with-dr-ehsan-rahimy-blt18909863eb2c3acd/overview

  • October 31 · 43 min· Video

    S4E3: The Retina Radar Season 4 With Dr. Arshad Khanani: Latest in DME Management in 2026 With Dr. Margaret Chang

    In this podcast, expert faculty discuss the latest clinical trial data and real-world studies on approved and emerging therapies for DME. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://vindicocme.com/mededtalks/3the-retina-radar-season-4-with-dr-arshad-khanani-latest-in-dme-management-in-2026-with-dr-margaret-chang-blt0238f9ad223ce3d2/overview

  • October 31 · 48 min· Video

    S4E2: The Retina Radar Season 4 With Dr. Arshad Khanani: Latest in nAMD Management in 2026 With Dr. Yasha Modi

    In this podcast, expert faculty discuss durability-focused treatment strategies and long-term clinical data to optimize outcomes for patients with nAMD. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://vindicocme.com/mededtalks/2the-retina-radar-season-4-with-dr-arshad-khanani-latest-in-namd-management-in-2026-with-dr-yasha-modi-bltbc205cf637dc6313/overview

  • October 28 · 13 min

    Updates from EURETINA, Retina Society, and AAO: nAMD, DME/DR, and RVO Treatment

    The treatment landscape for neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), diabetic retinopathy (DR), and retinal vein occlusion (RVO) continues to evolve, with ongoing efforts to improve durability and reduce treatment burden. Longer-acting second-generation anti-VEGF therapies, including aflibercept 8 mg and faricimab, have demonstrated the potential to extend dosing intervals while maintaining improved visual and anatomic outcomes across these retinal diseases. Emerging real-world and extension-study data are further informing the long-term safety, efficacy, and clinical application of these therapies. However, adherence barriers, undertreatment, safety considerations, access disparities, and uncertainty regarding patient selection continue to present challenges in achieving optimal outcomes. Clinicians must also understand differences in clinical trial design to critically interpret emerging evidence and apply durability data into individualized patient care. In this Rapid Response CE activity, experts in the field review abstracts presented at EURETINA, Retina Society, and The American Academy of Ophthalmology and discuss recent clinical evidence on approved second-generation anti-VEGF therapies to support evidence-based management of treatment naïve and previously treated patients with retinal diseases. To claim CME credit, please visit HealioCME.com and search for this activity title

  • August 28 · 10 min

    What's Next for Nutritional Strategies in AMD Care With Drs. Rishi Singh and Jeffry Gerson

    This podcast series delves into the evidence for oral micronutrient therapy in slowing the progression of age-related macular degeneration (AMD). In this episode, experts in the field discuss potential implications of expanded formulations of AMD supplements and interprofessional approaches for counseling patients. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20260828/3whats-next-for-nutritional-strategies-in-amd-care

  • August 28 · 12 min

    Emerging Evidence on B Vitamins and Expanded Nutritional Strategies in AMD With Drs. Rishi Singh and Julie Poteet

    This podcast series delves into the evidence for oral micronutrient therapy in slowing the progression of age-related macular degeneration (AMD). In this episode, experts in the field discuss the emerging evidence for incorporation of B vitamins into AMD supplementation and implications for evolving oral micronutrient strategies. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20260828/2emerging-evidence-on-b-vitamins-and-expanded-nutritional-strategies-in-amd

  • August 28 · 14 min· Video

    Current Evidence for Oral Micronutrient Therapy in AMD With Drs. Rishi Singh and Lejla Vajzovic

    This podcast series delves into the evidence for oral micronutrient therapy in slowing the progression of age-related macular degeneration (AMD). In this episode, experts in the field discuss the evidence base for AMD-specific supplementation and key considerations for incorporating oral micronutrient therapy into AMD management. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20260828/1current-evidence-for-oral-micronutrient-therapy-in-amd

  • August 3 · 13 min

    Updates from ASRS: nAMD, DME/DR, and RVO Treatment

    The treatment landscape for neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), diabetic retinopathy (DR), and retinal vein occlusion (RVO) continues to evolve, with ongoing efforts to improve durability and reduce treatment burden. Longer-acting second-generation anti-VEGF therapies, including aflibercept 8 mg and faricimab, have demonstrated the potential to extend dosing intervals while maintaining improved visual and anatomic outcomes across these retinal diseases. Emerging real-world and extension-study data are further informing the long-term safety, efficacy, and clinical application of these therapies. However, adherence barriers, undertreatment, safety considerations, access disparities, and uncertainty regarding patient selection continue to present challenges in achieving optimal outcomes. Clinicians must also understand differences in clinical trial design to critically interpret emerging evidence and apply durability data into individualized patient care. In this Rapid Response CE activity, experts in the field review abstracts presented at The American Society of Retina Specialists and discuss recent clinical evidence on approved second-generation anti-VEGF therapies to support evidence-based management of treatment naïve and previously treated patients with retinal diseases. To claim CME credit, please visit HealioCME.com and search for this activity title

  • June 1 · 16 min

    ARVO/RWC Updates: nAMD, DME/DR, RVO Treatments

    Second-generation anti-vascular endothelial growth factor (VEGF) therapies approved for the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) continue to be evaluated in ongoing clinical and real-world studies. Findings from these studies provide additional insights to guide the incorporation of these therapies into clinical practice, with the goal of enhancing visual and anatomic outcomes while reducing treatment burden in patients with retinal diseases. Although keeping up to date with emerging data can be challenging, doing so is essential for the optimal integration of second-generation anti-VEGF therapies into patient care. In this CE activity, experts in the field evaluate recent clinical evidence on approved second-generation anti-VEGF therapies to inform the management of treatment naive and previously treated patients with retinal diseases. To claim CME credit, please visit HealioCME.com and search for this activity title

  • May 29 · 16 min

    DME: Clinical Decision-Making for Implantable Drug Delivery Strategies with Drs. Dante Pieramici, Margaret Chang, and Jordan Graff

    In this podcast, Drs. Dante Pieramici, Margaret Chang, and Jordan Graff discuss utilizing implantable drug delivery systems in the management of a patient with DME. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20260529/2clinical-decision-making-for-implantable-drug-delivery-strategies-in-dme

  • May 29 · 15 min

    nAMD: Optimizing Procedural Approaches to Implantable Drug Delivery with Drs. Dante Pieramici, Margaret Chang, and Jordan Graff

    In this podcast, Drs. Dante Pieramici and Margaret Chang discuss utilizing implantable drug delivery systems in the management of a patient with nAMD. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20260529/1optimizing-procedural-approaches-to-implantable-drug-delivery-in-namd

  • Dec 30, 2025 · 26 min

    The Retina Radar With Dr. Arshad Khanani: 2025 Year in Review With Dr. Frank Holz

    In this podcast, expert clinicians will discuss exciting agents and therapeutic strategies for the management of retinal diseases. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20251230/18the-retina-radar-with-dr-arshad-khanani

  • Dec 30, 2025 · 34 min

    The Retina Radar With Dr. Arshad Khanani: Surgical Techniques and Instrumentation With Dr. Aleksandra Rachitskaya

    In this podcast, expert clinicians will discuss imaging devices, home monitoring, and the latest surgical techniques and instrumentation for retinal disease management. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20251230/16the-retina-radar-with-dr-arshad-khanani

  • Nov 26, 2025 · 30 min

    The Retina Radar With Dr. Arshad Khanani: Macular Telangiectasia With Dr. Glenn Jaffe

    In this podcast, expert clinicians will discuss macular telangiectasia, its pathogenesis, available treatments, and supporting clinical data. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20251126/15the-retina-radar-with-dr-arshad-khanani

  • Nov 26, 2025 · 32 min

    The Retina Radar With Dr. Arshad Khanani: Going Beyond Anti-VEGF in 2025 With Dr. Ashkan Abbey

    In this podcast, expert clinicians will discuss treatments with mechanisms of action that go beyond VEGF modulation and the supporting clinical data in managing retinal diseases. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20251126/13the-retina-radar-with-dr-arshad-khanani

  • Oct 31, 2025 · 41 min

    The Retina Radar With Dr. Arshad Khanani: Gene Therapy in 2025 With Drs. Avery and Pieramici

    In this podcast, expert clinicians will discuss the latest clinical trial data, including the efficacy and safety, of gene therapies for retinal diseases. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/ophthalmology/20251031/12the-retina-radar-with-dr-arshad-avery-and-pieramici

Showing 1–20 of 31 episodes